RaySearch Laboratories AB (publ)
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Johan Lof
- Full Time Employees
- 416
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- Sveavägen 44 Stockholm Sweden 111 34
- IPO Date
- Jun 9, 2015
- Website
- raysearchlabs.com
- Similar Companies
- Business
- RaySearch Laboratories AB (publ) RaySearch Laboratories AB is a Sweden-based medical technology company that develops advanced software solutions for radiation therapy and oncology, supporting thousands of clinics worldwide in cancer treatment. Founded in 2000 as a spin-off from Karolinska Institutet and headquartered at Eugeniavägen 18 in Stockholm, the company offers core products including RayStation, a flexible treatment planning system with adaptive therapy, multi-criteria optimization, and support for external beam therapy using photons, electrons, protons, helium, and carbon ions as well as HDR brachytherapy; RayPlan, a cost-effective planning system for essential radiation therapy techniques; RayCare, an oncology information system; and DrugLog, a chemotherapy quality assurance solution acquired from Pharmacolog AB. RaySearch operates globally through subsidiaries in the United States, Singapore, Belgium, France, Germany, and the United Kingdom, serving leading cancer centers with professional services in radiation oncology, project management, medical dosimetry, and medical physics. In July 2025, RaySearch entered a strategic partnership with Radiology Oncology Systems to integrate refurbished linear accelerators with its software, enhancing access to advanced cancer care and sustainability in radiation therapy practices while anticipating increased adoption of RayStation and RayCare.
RaySearch Laboratories AB (publ) (RSLBF) Q1 2026 Earnings Call Transcript
RaySearch Laboratories AB (publ) (RSLBF) Q4 2025 Earnings Call Transcript
RaySearch Laboratories AB (publ) (RSLBF) Q3 2025 Earnings Call Transcript
RaySearch Laboratories: Interim report April - June 2025
Interim report January 1 - March 31, 2025: RaySearch Laboratories
RaySearch Laboratories and Vision RT present innovations in surface guided treatment planning at ESTRO
Completed placing of shares in RaySearch Laboratories AB (publ)
Contemplated placement of existing shares in RaySearch Laboratories AB
RaySearch Laboratories: Year-end report 2024
RaySearch Laboratories to present ongoing development in liver ablation therapy* at RSNA 2024
RaySearch Laboratories: Interim report July - September 2024
RaySearch Laboratories: Interim report April - June 2024
RaySearch Laboratories: Interim report January 1 - March 31, 2024
RaySearch Laboratories: Year-end report 2023
RaySearch Laboratories: Interim report January 1 - September 30, 2023
Invitation to presentation of RaySearch's interim report for the third quarter of 2023
RaySearch Laboratories : Interim report January 1 - June 30, 2023
Invitation to presentation of RaySearch's interim report for the second quarter of 2023
UMCG in the Netherlands purchases Micro-RayStation for pre-clinical research, RaySearch Laboratories